GNAS may interact with MDM2, which may lead to MDM2-mediated degradation of TP53. Solomon et al. found that many kinds of TP53 mutations can regulate RAS in different ways, inducing a cancer-related gene signature [42]. Here, TP53 is linked to cancer.